Feedback / Questions
Orotecan (irinotecan oral) - Valent Tech, Edison Oncology
https://www.prnewswire.com/news-releases/edison-oncology-reports-promising-interim-data-from-ongoing-orotecan-clinical-trial-for-recurrent-pediatric-cancers-302110518.html
Apr 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next